Lookingbill et al., 1985 - Google Patents
Tissue production of androgens in women with acneLookingbill et al., 1985
- Document ID
- 13924393721111174111
- Author
- Lookingbill D
- Horton R
- Demers L
- Egan N
- Marks Jr J
- Santen R
- Publication year
- Publication venue
- Journal of the American Academy of Dermatology
External Links
Snippet
Precursor and target tissue-produced androgens were measured in the plasma of eighteen women with mild to moderate acne. Mean plasma levels of the precursor androgens (total testosterone, free testosterone, androstenedione, and dehydroepiandrosterone sulfate) …
- 239000003098 androgen 0 title abstract description 54
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/899—Menstrual disorder
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lookingbill et al. | Tissue production of androgens in women with acne | |
| US4496556A (en) | Topical applications for preventing dry skin | |
| Mango et al. | Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris | |
| Pochi et al. | Age-related changes in sebaceous gland activity | |
| Lucky et al. | Plasma androgens in women with acne vulgaris | |
| Gurpide et al. | Estrogen metabolism in normal and neoplastic endometrium | |
| Lane et al. | Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium. | |
| LEMAY et al. | Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d, l-norgestrel | |
| Hildreth et al. | Differences in breast cancer risk factors according to the estrogen receptor level of the tumor | |
| KAPPAS et al. | A study of “idiopathic” hirsutism; a transitional adrenal abnormality | |
| De Raeve et al. | Prepubertal acne: a cutaneous marker of androgen excess? | |
| Fukushima et al. | Tamoxifen in the treatment of infertility associated with luteal phase deficiency | |
| Kvedar et al. | Hirsutism: evaluation and treatment | |
| Hammond et al. | Estrogen replacement therapy | |
| Serafini et al. | Prolactin modulates peripheral androgen metabolism | |
| Phillipou et al. | Significance of steroid measurements in male pattern alopecia | |
| Laine et al. | Effect on peroxidase activity and specific binding of the hormone 17β-oestradiol and rat salivary glands | |
| Root et al. | Isosexual pseudoprecocity in a 6-year-old boy with a testicular interstitial cell adenoma | |
| MIYAKE et al. | Hormonal influences on the carbonic anhydrase concentration in the accessory reproductive tracts of the rat | |
| Speert | Local action of sex hormones | |
| Helzlsouer | Epidemiology, prevention, and early detection of breast cancer | |
| Prianishnikov | A functional model of the structure of the epithelium of normal, hyperplastic, and malignant human endometrium: A review | |
| Carlström et al. | Metabolism of estrone sulfate in human endometrium | |
| Aiman | Age, estrogen, and the endometrium | |
| Herrmann et al. | Interstitial-cell tumor of the testis with gynecomastia |